These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35186822)

  • 1. Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease.
    Choi IS; Lee MJ; Choi SA; Choi KS; Jeong IS; Cho HJ
    Front Pediatr; 2021; 9():792870. PubMed ID: 35186822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "Intermediate" CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease.
    Kim YS; Yang HJ; Kee SJ; Choi I; Ha K; Ki KK; Jeong IS; Cho HJ
    Pediatr Rheumatol Online J; 2021 May; 19(1):76. PubMed ID: 34059085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
    Matsuguma C; Wakiguchi H; Suzuki Y; Okada S; Furuta T; Ohnishi Y; Azuma Y; Ohga S; Hasegawa S
    Scand J Rheumatol; 2019 Nov; 48(6):491-496. PubMed ID: 31272272
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
    McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
    Front Immunol; 2021; 12():660506. PubMed ID: 34093549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q; Gong FQ; Shang SQ; Hu J
    Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
    Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
    Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
    Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
    Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
    Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease.
    Zhang H; Song HB; Wang DX; Deng HY; Sun WL
    Pak J Med Sci; 2022; 38(5):1165-1169. PubMed ID: 35799766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting factors for refractory kawasaki disease.
    Do YS; Kim KW; Chun JK; Cha BH; Namgoong MK; Lee HY
    Korean Circ J; 2010 May; 40(5):239-42. PubMed ID: 20514335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study.
    Zhang C; Zhang X; Shen J; Lu X; Zhang J; Chen S
    Mediators Inflamm; 2020; 2020():5213451. PubMed ID: 33293897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low FCMR mRNA expression in leukocytes of patients with Kawasaki disease six months after disease onset.
    Chang LS; Guo MM; Yan JH; Huang YH; Lo MH; Kuo HC
    Pediatr Allergy Immunol; 2020 Jul; 31(5):554-559. PubMed ID: 32073687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-1 and CD56 molecules.
    Rigal D; Vermot-Desroches C; Heitz S; Bernaud J; Alfonsi F; Monier JC
    Clin Immunol Immunopathol; 1994 Jun; 71(3):309-14. PubMed ID: 7515337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.
    Wang CL; Wu YT; Liu CA; Lin MW; Lee CJ; Huang LT; Yang KD
    Pediatrics; 2003 Feb; 111(2):E140-7. PubMed ID: 12563087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.